Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Deliang Fu

Matched on ORCID iD 0000-0003-1832-2000; OpenAlex author ID A5101682274, A5141088050. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
21
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 3 papers · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 10

  1. HRD Score: A Promising Biomarker for Genomic Instability Evaluation for Targeted Treatments Among Pancreatic Cancer Patients. Last author DOI 10.1177/15330338261469099↗
  2. Periarterial divestment for borderline and locally advanced pancreatic cancer: An analysis of 125 cases in a single center. Last author DOI 10.1016/j.surg.2025.109412↗
  3. High Glucose Promotes Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance and Invasion through Modulating ROS/MMP-3 Signaling Pathway. Co-author DOI 10.1155/2022/3243647↗
  4. GFAT1/HBP/O-GlcNAcylation Axis Regulates β-Catenin Activity to Promote Pancreatic Cancer Aggressiveness. Co-author DOI 10.1155/2020/1921609↗
  5. Dose surgical resection of hepatic metastases bring benefits to pancreatic ductal adenocarcinoma? A systematic review and meta-analysis. Co-author DOI 10.1016/j.ijsu.2017.10.066↗
  6. The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival. Co-author DOI 10.1016/s1499-3872(16)60168-6↗
  7. Triple-functional albumin-based nanoparticles for combined chemotherapy and photodynamic therapy of pancreatic cancer with lymphatic metastases. Co-author DOI 10.2147/ijn.s131295↗
  8. Application of Deuteporfin in the Metastatic Lymph Node Mapping of Pancreatic Cancer: An in vivo Study. Co-author DOI 10.1111/php.12574↗
  9. Characterization of the role of the photosensitizer, deuteporfin, in the detection of lymphatic metastases in a pancreatic cancer xenograft model. Co-author DOI 10.3892/ol.2015.3441↗
  10. Research on the relationships between pancreatic cancer and hyperglycemia in Chinese populations. Co-author DOI 10.1111/j.2040-1124.2012.00237.x↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chen Jin · 6 shared papers, 2015–2025 · strength 0.68
  2. Baian Tao · 2 shared papers, 2022–2026 · strength 0.48
  3. Feng Yang · 2 shared papers, 2017–2025 · strength 0.38
  4. Xinzhe Yu · 5 shared papers, 2015–2017 · strength 0.37
  5. Hang He · 2 shared papers, 2016–2025 · strength 0.36
  6. Xiaoyi Wang · 1 shared paper, 2026 · strength 0.33
  7. Jichun Gu · 3 shared papers, 2017–2022 · strength 0.32
  8. Ji Li · 1 shared paper, 2025 · strength 0.30
  9. Hengchao Li · 3 shared papers, 2015–2020 · strength 0.30
  10. Ji Li · 3 shared papers, 2013–2022 · strength 0.25
  11. Di Yang · 3 shared papers, 2016–2017 · strength 0.21
  12. Chunzeng Jia · 1 shared paper, 2020 · strength 0.16
  13. Yu Lan · 1 shared paper, 2020 · strength 0.16
  14. Junyuan Deng · 1 shared paper, 2022 · strength 0.15
  15. Lei Kong · 1 shared paper, 2022 · strength 0.15
  16. Jiali Du · 1 shared paper, 2022 · strength 0.15
  17. Zhongyi Guo · 2 shared papers, 2017 · strength 0.15
  18. Ji Li · 1 shared paper, 2015 · strength 0.06
  19. Lie Yao · 1 shared paper, 2016 · strength 0.06
  20. Yiming Li · 1 shared paper, 2013 · strength 0.04
  21. Shan Huang · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.